Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus bupivacaine versus bupivacaine alone for postoperative pain after upper limb orthopedic surgery
IRCT20160430027677N15Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and bupivacaine in postoperative pain (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Duration of sensory block, Duration of motor block and 1 more. Started Jun 2019; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20160430027677N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160430027677N15.